SE8902607L - Oxaza heterocykler och pharmaceutiska kompositioner innehaallande densamma - Google Patents

Oxaza heterocykler och pharmaceutiska kompositioner innehaallande densamma

Info

Publication number: SE8902607L
Authority: SE; Sweden
Prior art keywords: heterocycles; oxaza; agents; pharmaceutical compositions; compositions containing
Prior art date: 1988-08-01

Application number

SE8902607A

Other languages

English (en)

Other versions

SE8902607D0 (sv

SE504933C2 (sv

Inventor

S J Lee

Original Assignee

Biofor Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-08-01

Filing date

1989-07-27

Publication date

1990-02-26

1989-07-27 Application filed by Biofor Ltd filed Critical Biofor Ltd

1989-07-27 Publication of SE8902607D0 publication Critical patent/SE8902607D0/sv

1990-02-26 Publication of SE8902607L publication Critical patent/SE8902607L/sv

1997-05-26 Publication of SE504933C2 publication Critical patent/SE504933C2/sv

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
QXDOFVVNXBGLKK-UHFFFAOYSA-N 3-Isoxazolidinone Chemical compound OC1=NOCC1 QXDOFVVNXBGLKK-UHFFFAOYSA-N 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
FBXGQDUVJBKEAJ-UHFFFAOYSA-N 4h-oxazin-3-one Chemical compound O=C1CC=CON1 FBXGQDUVJBKEAJ-UHFFFAOYSA-N 0.000 abstract 1
239000000730 antalgic agent Substances 0.000 abstract 1
239000002260 anti-inflammatory agent Substances 0.000 abstract 1
229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
239000002221 antipyretic Substances 0.000 abstract 1
229940125716 antipyretic agent Drugs 0.000 abstract 1
206010003246 arthritis Diseases 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
239000002955 immunomodulating agent Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/04—Seven-membered rings having the hetero atoms in positions 1 and 2

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

SE8902607A 1988-08-01 1989-07-27 Oxazaheterocykler och deras mellanprodukter samt farmaceutiska kompositioner innehållande sagda oxazaheterocykler SE504933C2 (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/227,572 US4892870A (en)	1988-08-01	1988-08-01	Oxaza heterocycles and pharmaceutical compositions containing same

Publications (3)

Publication Number	Publication Date
SE8902607D0 SE8902607D0 (sv)	1989-07-27
SE8902607L true SE8902607L (sv)	1990-02-26
SE504933C2 SE504933C2 (sv)	1997-05-26

Family

ID=22853624

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8902607A SE504933C2 (sv)	1988-08-01	1989-07-27	Oxazaheterocykler och deras mellanprodukter samt farmaceutiska kompositioner innehållande sagda oxazaheterocykler

Country Status (9)

Country	Link
US (1)	US4892870A (sv)
JP (1)	JPH0278671A (sv)
AU (1)	AU3893389A (sv)
BE (1)	BE1002955A4 (sv)
CA (1)	CA1324130C (sv)
DE (1)	DE3925477A1 (sv)
FR (1)	FR2634764B1 (sv)
GB (1)	GB2221464B (sv)
SE (1)	SE504933C2 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW204339B (sv) *	1990-05-17	1993-04-21	Ciba Geigy Ag
AU9054291A (en) *	1990-11-26	1992-06-25	E.I. Du Pont De Nemours And Company	Herbicidal oxazine ethers
US5128330A (en) *	1991-02-19	1992-07-07	Biofor, Ltd.	Oxazinone substituted phosphines
US5271944A (en) *	1991-04-05	1993-12-21	Biofor, Ltd.	Pharmacologically enhanced formulations
US5215986A (en) *	1992-06-01	1993-06-01	Warner-Lambert Company	5-hydroxy-2-pyrimidinylmethylene oxaza heterocycles
JP3507124B2 (ja) *	1993-05-26	2004-03-15	塩野義製薬株式会社	ベンジリデン誘導体の製造法
DE69503769T2 (de) *	1994-03-09	1998-12-03	Pfizer Inc., New York, N.Y.	Isoxazoline verbindung zur hemmung tnf-freigabe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4552585A (en) *	1984-10-04	1985-11-12	Fmc Corporation	Herbicidal 2-(aminophenyl)methyl derivatives of 3-isoxazolidinones or 3-oxazinones

1988
- 1988-08-01 US US07/227,572 patent/US4892870A/en not_active Expired - Lifetime
1989
- 1989-07-14 CA CA000605775A patent/CA1324130C/en not_active Expired - Fee Related
- 1989-07-25 AU AU38933/89A patent/AU3893389A/en not_active Abandoned
- 1989-07-27 SE SE8902607A patent/SE504933C2/sv not_active IP Right Cessation
- 1989-07-31 FR FR8910300A patent/FR2634764B1/fr not_active Expired - Fee Related
- 1989-08-01 GB GB8917527A patent/GB2221464B/en not_active Expired - Fee Related
- 1989-08-01 JP JP1200167A patent/JPH0278671A/ja active Pending
- 1989-08-01 BE BE8900823A patent/BE1002955A4/fr not_active IP Right Cessation
- 1989-08-01 DE DE3925477A patent/DE3925477A1/de not_active Withdrawn

Also Published As

Publication number	Publication date
US4892870A (en)	1990-01-09
SE8902607D0 (sv)	1989-07-27
CA1324130C (en)	1993-11-09
AU3893389A (en)	1990-02-01
BE1002955A4 (fr)	1991-10-01
GB8917527D0 (en)	1989-09-13
SE504933C2 (sv)	1997-05-26
FR2634764B1 (fr)	1994-01-14
FR2634764A1 (fr)	1990-02-02
JPH0278671A (ja)	1990-03-19
GB2221464A (en)	1990-02-07
GB2221464B (en)	1992-07-08
DE3925477A1 (de)	1990-02-08

Similar Documents

Publication	Publication Date	Title
IE862554L (en)	1987-03-27	Pharmaceutical compositions
DK0512090T3 (da)	1997-06-16	Behandling af inflammation
ES2042520T3 (es)	1993-12-16	Composiciones farmaceuticas que contienen el ester metilico de levodopa, preparacion y aplicaciones terapeuticas del mismo.
BR9402558A (pt)	1995-03-28	Compostos, processo para sua preparação, composições farmacêuticas e uso dos compostos
NO870241D0 (no)	1987-01-20	Hypoglykemiske tiazolidindioner.
NO872686D0 (no)	1987-06-26	Nye farmakologiske forbindelser.
IT8621358A0 (it)	1986-08-01	Composizione farmaceutica adattivita' analgesica.
DE3768419D1 (de)	1991-04-11	Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
FI920023A0 (fi)	1992-01-03	Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
IT1148277B (it)	1986-11-26	Derivati encefalinici dotati di attivita' analgesica e tranquillante neurolettica e procedimento per la loro preparazione
SE8404065D0 (sv)	1984-08-10	Novel biologically active compounds
ATE38991T1 (de)	1988-12-15	In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
IT1145403B (it)	1986-11-05	Derivati di 1,2-diidro-2-osso-4-fenil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorie
SE8902607L (sv)	1990-02-26	Oxaza heterocykler och pharmaceutiska kompositioner innehaallande densamma
IT8922341A0 (it)	1989-11-10	Composti piperidin-triazinici atti all'impiego come stabilizzanti per materiali organici
FI810380L (fi)	1981-08-14	Fenylpiperazinderivat av 1,3,4-oxadiazolylfenoler deras framstaellning och dessa innehaollande terapeutiska aemnen
IT8921380A0 (it)	1989-07-28	Composti piperazin piperidinici atti all'impiego come stabilizzanti per materiali organici.
MX9203585A (es)	1992-09-01	Derivados de fenotiazina y composiciones farmaceuticas que los contienen.
FI851365L (fi)	1985-10-06	Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
DE3785288D1 (de)	1993-05-13	Polyarylthioetherzusammensetzung und formkoerper daraus.
KR890009868A (ko)	1989-08-04	1-메틸-β-옥소-α-(페닐카바모일)-2- 피롤프로피오니트릴의 트로메트아민염
IT7819638A0 (it)	1978-01-26	Vite autofilettante nonche'procedimento per la sua fabbricazione e ganascia di cilindratura per l'attuazione del procedimento.
ATE113949T1 (de)	1994-11-15	Alpha-adrenergische rezeptorantagonisten.
ES2062313T3 (es)	1994-12-16	13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
ATE53004T1 (de)	1990-06-15	Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen.

Legal Events

Date	Code	Title	Description
2003-03-04	NUG	Patent has lapsed